BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Cao HC, Chen XM, Xu W. Determination of platelet-activating factor by reverse phase high-performance liquid chromatography and its application in viral hepatitis. World J Gastroenterol 2005; 11(46): 7364-7367 [PMID: 16437644 DOI: 10.3748/wjg.v11.i46.7364]
URL: https://www.wjgnet.com/1007-9327/full/v11/i46/7364.htm
Number Citing Articles
1
Ronan Lordan, Alexandros Tsoupras, Ioannis Zabetakis. Platelet activation and prothrombotic mediators at the nexus of inflammation and atherosclerosis: Potential role of antiplatelet agentsBlood Reviews 2021; 45: 100694 doi: 10.1016/j.blre.2020.100694
2
Paraskevi Detopoulou, Tzortzis Nomikos, Elizabeth Fragopoulou, George Stamatakis, Demosthenes B. Panagiotakos, Smaragdi Antonopoulou. PAF and its metabolic enzymes in healthy volunteers: Interrelations and correlations with basic characteristicsProstaglandins & Other Lipid Mediators 2012; 97(1-2): 43 doi: 10.1016/j.prostaglandins.2011.10.003
3
Su Jung Kim, Sung Hoon Back, Jung Min Koh, Hyun Ju Yoo. Quantitative determination of major platelet activating factors from human plasmaAnalytical and Bioanalytical Chemistry 2014; 406(13): 3111 doi: 10.1007/s00216-014-7736-5
4
Meredith A. Jackson, Shrusti S. Patel, Fang Yu, Matthew A. Cottam, Evan B. Glass, Ella N. Hoogenboezem, R. Brock Fletcher, Bryan R. Dollinger, Prarthana Patil, Danielle D. Liu, Isom B. Kelly, Sean K. Bedingfield, Allyson R. King, Rachel E. Miles, Alyssa M. Hasty, Todd D. Giorgio, Craig L. Duvall. Kupffer cell release of platelet activating factor drives dose limiting toxicities of nucleic acid nanocarriersBiomaterials 2021; 268: 120528 doi: 10.1016/j.biomaterials.2020.120528